Terms: = Breast cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Clinical Outcome
37 results:
1. Conservative interventions and clinical outcome measures used in the perioperative rehabilitation of breast cancer patients undergoing mastectomy: a scoping review.
Mathieu J; Daneau C; Lemeunier N; Doyon A; Marchand AA; Descarreaux M
BMC Womens Health; 2022 Aug; 22(1):343. PubMed ID: 35974334
[TBL] [Abstract] [Full Text] [Related]
2. clinical features and prognostic factors of breast cancer in young women: a retrospective single-center study.
Wang W; Tian B; Xu X; Zhang X; Wang Y; Du L; Jing J
Arch Gynecol Obstet; 2023 Mar; 307(3):957-968. PubMed ID: 35835921
[TBL] [Abstract] [Full Text] [Related]
3. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
Negrao MV; Skoulidis F; Montesion M; Schulze K; Bara I; Shen V; Xu H; Hu S; Sui D; Elamin YY; Le X; Goldberg ME; Murugesan K; Wu CJ; Zhang J; Barreto DS; Robichaux JP; Reuben A; Cascone T; Gay CM; Mitchell KG; Hong L; Rinsurongkawong W; Roth JA; Swisher SG; Lee J; Tsao A; Papadimitrakopoulou V; Gibbons DL; Glisson BS; Singal G; Miller VA; Alexander B; Frampton G; Albacker LA; Shames D; Zhang J; Heymach JV
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376553
[TBL] [Abstract] [Full Text] [Related]
4. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
[TBL] [Abstract] [Full Text] [Related]
5. Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis.
Wu N; Fu F; Chen L; Lin Y; Yang P; Wang C
Clin Transl Oncol; 2020 Apr; 22(4):474-485. PubMed ID: 31222450
[TBL] [Abstract] [Full Text] [Related]
6. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
Veenstra C; Karlsson E; Mirwani SM; Nordenskjöld B; Fornander T; Pérez-Tenorio G; Stål O
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1845-1856. PubMed ID: 31025094
[TBL] [Abstract] [Full Text] [Related]
7. clinical outcomes Associated with Drug-Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review.
Sharma M; Vadhariya A; Chikermane S; Gopinathan S; Chavez-MacGregor M; Giordano SH; Johnson ML; Holmes HM
Drugs Aging; 2019 Apr; 36(4):341-354. PubMed ID: 30714077
[TBL] [Abstract] [Full Text] [Related]
8. Increased Expression of c-met is Associated with Chemotherapy-Resistant breast cancer and Poor clinical outcome.
Jia L; Yang X; Tian W; Guo S; Huang W; Zhao W
Med Sci Monit; 2018 Nov; 24():8239-8249. PubMed ID: 30444219
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
Mon AM; MacKinnon AC; Traktman P
PLoS One; 2018; 13(9):e0203397. PubMed ID: 30180179
[TBL] [Abstract] [Full Text] [Related]
10. Should planned/desired pregnancy be considered an absolute contraindication to breast reconstruction with free abdominal Flaps? A retrospective case series and systematic review.
Moshrefi S; Kanchwala S; Momeni A
J Plast Reconstr Aesthet Surg; 2018 Sep; 71(9):1295-1300. PubMed ID: 29970346
[TBL] [Abstract] [Full Text] [Related]
11. The Predictive Significance of metastasis-Associated in Colon cancer-1 (MACC1) in Primary breast cancer.
Prguda-Mujic J; Milde-Langosch K; Mueller V; Suljagic M; Coric J; Ler D
Ann Clin Lab Sci; 2018 Mar; 48(2):191-196. PubMed ID: 29678846
[TBL] [Abstract] [Full Text] [Related]
12. The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract] [Full Text] [Related]
13. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
[TBL] [Abstract] [Full Text] [Related]
14. met and its ligand HGF are associated with clinical outcome in breast cancer.
Veenstra C; Pérez-Tenorio G; Stelling A; Karlsson E; Mirwani SM; Nordensköljd B; Fornander T; Stål O
Oncotarget; 2016 Jun; 7(24):37145-37159. PubMed ID: 27175600
[TBL] [Abstract] [Full Text] [Related]
15. The Prognostic Value of Tumor-Infiltrating Lymphocytes in breast cancer: A Systematic Review and meta-Analysis.
Mao Y; Qu Q; Chen X; Huang O; Wu J; Shen K
PLoS One; 2016; 11(4):e0152500. PubMed ID: 27073890
[TBL] [Abstract] [Full Text] [Related]
16. Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
Sameni M; Tovar EA; Essenburg CJ; Chalasani A; Linklater ES; Borgman A; Cherba DM; Anbalagan A; Winn ME; Graveel CR; Sloane BF
Clin Cancer Res; 2016 Feb; 22(4):923-34. PubMed ID: 26432786
[TBL] [Abstract] [Full Text] [Related]
17. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.
Paulis YW; Huijbers EJ; van der Schaft DW; Soetekouw PM; Pauwels P; Tjan-Heijnen VC; Griffioen AW
Oncotarget; 2015 Aug; 6(23):19634-46. PubMed ID: 26189059
[TBL] [Abstract] [Full Text] [Related]
18. A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome.
Soundararajan R; Paranjape AN; Barsan V; Chang JT; Mani SA
Sci Rep; 2015 Jun; 5():11766. PubMed ID: 26123483
[TBL] [Abstract] [Full Text] [Related]
19. Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer.
Henneman L; van Miltenburg MH; Michalak EM; Braumuller TM; Jaspers JE; Drenth AP; de Korte-Grimmerink R; Gogola E; Szuhai K; Schlicker A; Bin Ali R; Pritchard C; Huijbers IJ; Berns A; Rottenberg S; Jonkers J
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8409-14. PubMed ID: 26100884
[TBL] [Abstract] [Full Text] [Related]
20. methylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancer.
Chen LH; Liu DW; Chang JL; Chen PR; Hsu LP; Lin HY; Chou YF; Lee CF; Yang MC; Wen YH; Hsu WL; Weng CF
J Exp Clin Cancer Res; 2015 Feb; 34(1):20. PubMed ID: 25880247
[TBL] [Abstract] [Full Text] [Related]
[Next]
